A219 BIOLOGIC USE DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE AND ASSOCIATED NEONATAL OUTCOMES: A RETROSPECTIVE CHART REVIEW

BACKGROUND: Biologics are the mainstay of therapy for patients with advanced inflammatory bowel disease (IBD). Most biologics readily undergo placental transfer during the second trimester and remain detectable in infant serum for up to 12 months. Therefore, most clinical guidelines currently recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyakumar, Y, O'Connor, K, Huang, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991354/
http://dx.doi.org/10.1093/jcag/gwac036.219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991354/
http://dx.doi.org/10.1093/jcag/gwac036.219

Ejemplares similares